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Available online 16 September 2014AbstractSarcopenic obesity (SO) in the elderly is associated with a loss of independence and the occurrence of metabolic complications.
Despite this clinical importance, the associations of SO with various health outcomes in Asian elders are unclear. This study aimed
to examine the association of SO with the prevalence of chronic illness and mobility limitations among 1204 subjects (576 men and
628 women) over the age of 60 from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1, 2010).
The patients were placed in four categories based on body composition: normal, sarcopenic non-obese, normal obese, and SO. Data
regarding functional dimensions were extracted from the EQ-5D in the KNHANES data (i.e., mobility, self-care, and usual ac-
tivities). Pain/discomfort data were also extracted. The prevalence of SO was higher among the women than the men (7.2% vs.
4.1%). Hypertension and arthritis were associated with increased likelihoods of SO. People with SO were more likely to report
problems in mobility (OR: 3.34, 95% CI, 1.97e5.65), self-care (men: OR: 2.92, 95% CI, 1.05e8.07, women: OR: 2.33, 95% CI,
1.29e4.21), and usual activity (men: OR: 2.28, 95% CI, 1.02e5.08, women: OR: 2.13, 95% CI, 1.29e3.52). In conclusion, our
results showed that SO was associated with mobility, self-care, and usual activity problems. With the rapid ageing that is occurring
in Korea, more attention should be given to the prevention and management of sarcopenic obese seniors.
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combined with losses of muscle mass and strength. The
loss of muscle reduces the mass of available insulin-
responsive target tissue, which promotes insulin resis-
tance, which in turn, promotes metabolic syndrome
and obesity [1].
Furthermore, increasing fat mass promotes the
production of interleukin-6, tumour necrosis factor
alpha, and other adipokines that further promoteniversity, Dalian University of Technology, Kokushikan University.
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catabolic effect on the muscle. This cycle that is
created leads to more gain in fat and more loss of
muscle, until a threshold is crossed, and functional
consequences, such as disability and illness occur.
Among the consequences of obesity in later life are an
increased risk of cardiometabolic complications, insulin
resistance, type 2 diabetes, dyslipidaemia, knee replace-
ment, dementia and cardiovascular disease [2e5].
Similarly, the loss of muscle mass associated with
the ageing process is called sarcopenia and represents
an impaired state of health that involves cardiovascular
risk factors including glucose intolerance and meta-
bolic syndrome, mobility disorders, impaired abilities
to perform activities of daily living, increased risks of
falls and fractures, disability, loss of independence and
an increased risk of death [6e8].
Given the occurrence of these two greatest epide-
miological trends in ageing, it is possible that the
combination of obesity and sarcopenia is associated
with an even greater risk. Baumgartner et al. [9] pro-
posed criteria for a new condition that combines sar-
copenia and obesity that has been termed “sarcopenic
obesity (SO)”. Sarcopenic obesity is characterised by
reduced skeletal muscle mass coupled with increased
adiposity within the same elderly person.
Understanding the associations of sarcopenic
obesity with health outcomes, such as cardiovascular
risk and mobility problems, is a crucial priority for
public-health policy making because these associa-
tions affect both public health promotion programs
and long-term care. Villareal et al. [10] provided one
of the first systematic evaluations of sarcopenic
obesity relative to both nonsarcopenic obese and
adults of comparable ages. These authors compared
52 obese elderly adults, 52 nonobese frail adults, and
52 nonobese, nonfrail persons who were matched for
age and sex. Compared with the nonobese nonfrail
group, the obese and nonobese frail groups had low in
physical performance and peak aerobic power.
Previous studies have produced conflicting results.
Initial evidence indicated that when obesity and muscle
impairment co-exist, they act synergistically on the
risks of developing multiple health-related outcomes.
In the New Mexico Elder Health Survey, sarcopenic
obese participants were more likely to be disabled than
were participants who were only obese or sarcopenic
[11].
After 8-years of follow-up in the New Mexico
Aging Process Study, Baumgartner and his colleagues
[9] reported that the SO elderly were 2.5 times more
likely to experience declines in physical functioncompared to the elderly with normal body composi-
tions. Sarcopenia or obesity alone did not increase this
risk. Further, Stephen and Janssen [12] reported that
sarcopenic obesity is associated with a modest
increase in the risks of cardiovascular disease (CVD)
and congestive heart failure (CHF). These authors re-
ported that neither obesity nor sarcopenia alone
significantly predicted CVD, but the simultaneous
occurrence of these conditions (i.e., sarcopenic
obesity) increased the risk of CVD by 23%.
However, two other cross-sectional studies based on
the NHANES III [13] and a sample of older women [14]
found no association between obesity and functional
decline in the presence of low muscle mass. In the
InCHIANTI study, older persons with high BMIs and
low strength were found to experience steeper declines
in walking speed and greater probabilities of mobility
disability than were those with either poor muscle
strength or obesity alone [15].
While previous studies have provided some con-
tradictory findings, they have been limited to Western
countries, and more research is needed to clarify the
effects sarcopenic obesity on the health outcomes of
the Asian elderly population. The Korean population is
rapidly ageing, and approximately 10.3% of the
Korean population over the age of 65 years in 2008.
This percentage is expected to rapidly rise to 20.3% in
2027 and 34.4% in 2050 [16].
To bridge the knowledge gap between Western and
Asian countries, the primary purpose of this study was
to examine the associations of sarcopenic obesity with
health outcomes such as chronic disease and functional
outcomes among older Koreans.
Method
Study subjects
The data for this study were obtained from a
cross-sectional and nationally representative survey
conducted by the Korean Ministry of Health and
Welfare in 2010. In the 1st-year data from the Fifth
Korean National Health and Nutrition Examination
Survey (KNHANES-V-1; JanuaryeDecember, 2010),
the participants were non-institutionalised civilians
who were selected with a stratified, multistage,
probability-sampling design based on geographic
area, sex, and age group that was conducted based
on the household registries.
A total of 3840 households selected from 192
survey locations were surveyed. The overall partici-
pation rate was 82.8%. All participants provided
Table 1
Categorisation of body composition.
Normal
n (%)
Sarcopenia
n (%)
Obese
n (%)
Sarcopenic
obese n (%)
Male 543 (64.3) 15 (2.0) 215 (25.4) 33 (3.9)
Female 555 (52.9) 15 (1.4) 359 (34.2) 73 (7.0)
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in the survey and the use of their data for research
purposes.
The participants completed a health interview, a
health behaviour survey, a nutritional survey, and a
medical examination. The health interview included
demographic characteristics (i.e., age, income, edu-
cation, occupation, marital status, and current
smoking status). In the KNHANES V-1, there were
2028 participants aged 60 years. Of those, dual
energy absorptiometry (DXA) scan data for the
measurement of BMD were available for 1513 older
participants.
Education was classified as follows: elementary
school, middle school, high school, and >college
or university. Occupation was divided into currently
working and not currently working. Marital status was
classified by the presence or absence of spouse. Cur-
rent smoking was categorised as yes or no. The cate-
gorical variables were analysed with chi-square tests,
and the continuous variables were analysed with in-
dependent t-tests.
Chronic condition
The health interviews surveyed data regarding
major chronic diseases by asking respondents ques-
tions such as “Have you experienced any chronic dis-
ease during past years?” and “Was the chronic disease
diagnosed by a physician?”. “Chronic diseases” were
defined as diseases lasting at least three months within
the preceding 12 months. Seven categories of major
chronic diseases that accorded with the International
Classification of Diseases, 10th Revision Clinical
Modification (ICD-10-CM) were selected for this study
and included the following: 1) hypertension (I10eI15);
2) hyperlipidaemia (I70); 3) stroke (I60eI69); 4) cor-
onary heart disease (I20, I23eI25); 5) arthritis
(M05eM09, M11eM13, M15eM19); 6) diabetes
(E10eE14); and 7) depression.
Mobility limitation
Impairment of mobility was measured using the
mobility domain of the Korean version of the European
quality of life questionnaire (EQ-5D). The EQ-5D is a
composite measure of health outcomes that consists of
five domains: mobility, self-care, daily activity, pain/
discomfort, and anxiety/depression. The mobility
index consists of the following three statements for
which participants select the statement that best
described them: ‘I have no problem walking about’, ‘Ihave some problems walking about’ and ‘I am confined
to a bed’.
Definition of sarcopenic obesity
In this study, obesity was defined by a body fat
percentage above the 60th percentile of the study
sample. Sarcopenia was defined with a modification of
original definition of Janssen et al. [17] i.e., sarcopenia
was defined as an appendicular skeletal muscle mass
(ASM; the sum of the muscle mass in the bilateral
upper and lower limbs divided by the weight (%) two
SDs below the sex-specific mean for young adults).
This definition is termed the modified skeletal muscle
mass index (SMI). In this study, the two SDs cutoffs
for the sex-specific young normal people were 26.5%
for men and 20.8% for women.
Body composition was categorised into four cate-
gories: normal, sarcopenic non-obese, normal obese,
and sarcopenic-obese (SO). Table 1 shows the pro-
portions of participants in each group.
To directly compare the normal body composition
and sarcopenic obese groups in terms of the various
health outcomes, we excluded the obesity without
sarcopenia and sarcopenia without obesity groups. For
these comparisons, we estimated the prevalence of SO
according to age group, sex, and region. Additionally,
we explored the potential risk factors relations with the
various other related factors after adjusting for age.
Statistical analyses
The statistical analyses were conducted using SPSS
software version 17.0 (SPSS, Chicago, IL, USA). The
prevalence of SO was estimated after adjusting for
weight. Weight was adjusted for to reflect the entire
Korean elderly population. A sample weight was
assigned to each sample according to the following
three steps: calculation of the base weight, adjustment
for non-responses, and post-stratification adjustment to
match the total number in the previous census popu-
lation. The categorical variables were analysed with
chi-square tests, and the continuous variables were
analysed with independent t-tests.
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multiple logistic regression analysis. The continuous
variables were divided into quartiles to evaluate the
linear trends. Each of the associated factors was ana-
lysed separately after adjusting for age.
Results
Characteristics of the study population
The general characteristics of the study population
are shown in Table 2. The participants' mean ages were
69.02 ± 6.27 yr old for the men and 69.95 ± 6.71 yr
old for the women. Because the risk factors for meta-
bolic syndrome were different between the genders, the
following analyses of the risk factors between the
normal body composition group and the sarcopenic
obesity group were conducted separately by gender as
shown in Table 3.
The prevalences of SO were 4.1% (95% CI ¼ 2.87
to 1.64) for the men and 7.3% (95% 95% CI ¼ 2.52
to 0.95) for the women. Table 3 shows the risk factors
associated with metabolic syndrome for the normal and
sarcopenic obesity groups.
The mean ages were not different between the
normal and SO groups in either the men or women.
The WCs and BMIs were much higher in sarcopenic
obesity group among both the males (t ¼ 15.99,
p < 0.001; t ¼ 12.40, p < 0.001) and females
(t ¼ 24.17, p < 0.001; t ¼ 19.04, p < 0.001).
The insulin levels of the SO group were much
higher than those of the normal group among both theTable 2
General characteristics of the population.a
Variables Men (n ¼ 808)
mean ± SD
Women (n ¼ 1049)
mean ± SD
Age (yr) 69.02 ± 6.27 69.95 ± 6.71
Height (cm) 165.68 ± 5.67 151.71 ± 5.74**
Weight (kg) 64.16 ± 9.25 55.90 ± 9.11**
WC (cm) 85.12 ± 9.16 83.14 ± 0.38**
BMI (kg/m2) 23.34 ± 2.93 24.24 ± 3.41**
Total body fat 23.58 ± 5.46 35.30 ± 5.80**
ASM (kg) 20.98 ± 28.14 14.26 ± 20.63**
SMI (%) 32.8 ± 29.63 25.7 ± 28.19**
Fasting glucose 105.23 ± 25.97 101.79 ± 22.51*
Total cholesterol 181.53 ± 33.19 198.75 ± 37.15**
HDL cholesterol 48.79 ± 13.06 51.32 ± 12.20**
Triglyceride 144.14 ± 100.51 140.48 ± 80.38
LDL cholesterol 107.43 ± 30.13 122.28 ± 32.73**
*p < 0.05. **p < 0.01. Abbreviations: WC, waist circumference;
BMI, body mass index; ASM, appendicular skeletal muscle mass;
SMI, modified skeletal muscle mass index.
a Analysed by independent t-test.male (t ¼ 5.10, p < 0.001; t ¼ 5.09, p < 0.001) and
females. The total cholesterol and LDL levels of the
SO group were much higher than those of the normal
group only among the females (t ¼ 3.58, p < 0.001;
t ¼ 2.08, p < 0.05).
In the male, the HDL-C of the SO group was lower
than that of the normal group.
Factors associated with sarcopenic obesity
Tables 4 and 5 illustrate the factors associated with
sarcopenic obesity. We investigated the relationships
between sarcopenic obesity and various health out-
comes. Hypertension (men: odds ratio [OR], 3.14, 95%
CI, 1.51e6.53, women: OR: 2.80, 95% CI, 1.65e4.73)
and arthritis (women only: OR: 2.39, 95% CI,
1.43e3.99) were associated with significantly
increased likelihoods of SO.
Older persons with SO were more likely to report
problems with mobility (OR: 3.34, 95% CI, 1.97e5.65),
self-care (men: OR: 2.92, 95% CI, 1.05e8.07, women:
OR: 2.33, 95% CI, 1.29e4.21), and usual activities
(men: OR: 2.28, 95% CI, 1.02e5.08, women: OR: 2.13,
95% CI, 1.29e3.52).
Discussion
The effects of sarcopenic obesity on functional
limitations and physical function have been given
considerable attention in the gerontology literature;
however, the effects of this condition on associated
diseases, such as cardiovascular disease, have been
poorly studied, particularly among Asian elderly. To
our knowledge, this is the second cross-sectional study
to examine the relationships between sarcopenic
obesity, functional capacity, and the risk factors for
cardiovascular disease.
In general, normal ageing entails weight gain for
most adults gain between the third and sixth decades;
this weigh gain levels off, and modest amounts of
weight begin to be lost though the ninth decade.
Although declines in muscle mass have been docu-
mented as early as the fourth or fifth decade, sarco-
penia is observed in 5e10% of adults in their sixties,
and this rate rises to over 50% in healthy, ambulatory,
community-dwelling adults over the age of 80 [11]. In
this study, the prevalence rates of SO were 4.1%
among men and 7.3% among women. Our results
revealed that the prevalence of sarcopenic obesity in
men was lower than those observed in the Korean
Sarcopenic Obesity study and the study of [18] that
analysed the KNAHENS IV data (4.1% vs. 9.7% vs.
Table 3
Comparison of the metabolic risk factors between the normal and sarcopenic obesity groups.
Variables Mena t Womena t
Normal
(n ¼ 543)
Sarcopenic
obesity (n ¼ 33)
Normal
(n ¼ 555)
Sarcopenic
obesity (n ¼ 73)
Age 69.14 ± 6.37 67.76 ± 6.73 0.54 69.76 ± 7.16 70.55 ± 6.62 0.89
WC (cm) 80.61 ± 6.39 98.87 ± 5.9 15.99*** 76.52 ± 5.79 94.28 ± 6.67 24.17***
BMI (kg/m2) 22.04 ± 2.31 27.28 ± 3.05 12.40*** 22.38 ± 2.34 28.21 ± 3.51 19.04***
Fasting glucose (mg/dl) 103.97 ± 25.90 112.63 ± 37.89 1.73 98.46 ± 19.48 106.15 ± 28.28 2.74**
Insulin (microIU/mL) 9.19 ± 5.21 13.16 ± 6.26 5.10*** 9.96 ± 4.46 13.11 ± 5.21 5.09***
Total cholesterol (mg/dl) 181.24 ± 32.56 178.23 ± 29.77 0.49 195.51 ± 35.04 213.36 ± 48.11 3.58***
HDL-C (mg/dl) 50.64 ± 13.64 44.57 ± 10.70 2.84** 52.60 ± 12.16 51.69 ± 14.63 0.54
LDL-C (mg/dl) 104.47 ± 29.97 104.57 ± 27.18 0.10 119.01 ± 32.67 137.80 ± 31.31 2.08*
TG (mg/dl) 133.52 ± 104.25 141.47 ± 64.81 0.51 129.69 149.52 ± 79.27 1.87
*p< 0.05, **p < 0.01, ***p< 0.001. Abbreviations:WC, waist circumference; BMI, bodymass index; HDL-C, high density lipoprotein cholesterol;
LDL-C, low density lipoprotein cholesterol; TG, triglyceride.
a The data are presented as the mean ± SD unless otherwise indicated.
114 S.-Y. Hong / Pacific Science Review 16 (2014) 110e1166.1%, respectively). Additionally, the prevalence
among women was lower or identical to those observed
in the Korean Sarcopenic Obesity study and the study
of Hwang et al. [18] that analysed the KNAHENS IV
data (7.3% vs. 11.8% vs. 7.3%, respectively). These
differences might reflect differences in the definitions
of sarcopenic obesity and the methods of subject
recruitment.
In a previous study, Asian populations were found
to be more prone to abdominal obesity and low skeletal
muscle mass with increased insulin resistance
compared with their Western counterparts [19]. Thus,
the effect of a sarcopenic obese status on the risks for
cardiovascular disease and functional limitations mightTable 4
Factors associated with sarcopenic obesity.
Category Men OR
(95% CI)a
Women OR
(95% CI)
Hypertension None 1.0 1.0
Yes 3.14 (1.51e6.53) 2.80 (1.65e4.73)*
Hyperlipidaemia None 1.0 1.0
Yes 1.25 (0.81e1.94) 1.19 (0.82e1.72)
Stroke None 1.0 1.0
Yes 1.03 (0.48e2.21) 0.92 (0.4e2.1)
Ischaemic
heart disease
None 1.0 1.0
Yes 1.19 (0.72e1.96) 0.99 (0.55e1.52)
Arthritis None 1.0 1.0
Yes 1.83 (0.80e4.20) 2.39 (1.43e3.99)*
Diabetes None 1.0 1.0
Yes 1.22 (0.79e1.90) 2.01 (0.82e1.76)
Depression None 1.0 1.0
Yes 0.97 (0.43e2.21) 0.85 (0.52e1.40)
Activity
limitation
None 1.0 1.0
Yes 1.51 (0.66e3.45) 1.69 (1.01e2.85)*
* p < .05
a The data were analysed by logistic regression. Sarcopenic obesity.also be more strongly associated with it. Kim et al. [20]
reported that men with diabetes have decreased lean
body mass and increased body fat mass relative to
nondiabetic subjects, although these groups have
similar BMIs. Furthermore, compared to their nondi-
abetic counterparts, both men and women with dia-
betes have decreased SMI values. However, in a cross-
sectional analysis of the Health ABC study that
included Western elderly subjects, patients with type 2
diabetes exhibited increases in lean body mass and
body fat mass compared with subjects without diabetes
because, compared to the nondiabetic subjects, those
with diabetes were more obese and higher BMIs.
Appendicular skeletal mass divided by height
squared is a metric that is widely used to define sar-
copenia, but this metric has been criticised because
body fat is not taken into consideration. Thus, the
application of this metric might have been a limited
factor that resulted in an underestimation of sarcopenia
among overweight or obese subjects.Table 5
Association of quality of life and SO.
Category Men OR
(95% CI)
Women OR
(95% CI)
EQ5D
mobility
None 1.0 1.0
Problem 1.94 (0.91e4.12) 3.34 (1.97e5.65)**
EQ5D
self-care
None 1.0 1.0
Problem 2.92 (1.05e8.07)* 2.33 (1.29e4.21)**
EQ5D usual
activity
None 1.0 1.0
Problem 2.28 (1.02e5.08)* 2.13 (1.29e3.52)**
EQ5D pain None 1.0 1.0
Problem 1.68 (0.81e3.46) 1.53 (0.92e2.52)
EQ5D
depression
None 1.0 1.0
Problem 1.95 (0.72e5.30) 1.75 (1.0e3.08)
* p < 0.05, ** p < 0.01
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and fat mass, obesity in the elderly acts synergistically
with sarcopenia tomaximise disability. Previous research
reported that, as they age, the ‘fat frail’ is exposed to
adverse effects of both factors; i.e., weakness due to
sarcopenia and the need to carry greater weight due to
obesity [21].
With the increase in obesity that has occurred in the
past two decades, the prevalence of obese elderly has
risen, and the effects of sarcopenic obesity are likely to be
dramatic in the next decade. In conditions such as ma-
lignancy, rheumatoid arthritis and ageing, lean bodymass
is lost, while fat mass can be preserved or even increased,
and this condition is called sarcopenic obesity.
It had long been thought that age-related losses in
weight and muscle mass are largely responsible for
muscle weakness in older people [22]. While weight
changes vary widely between individuals, certain pat-
terns of age-related changes in body composition have
been observed. In ageing men, the percentage of fat
mass initially increases and then levels off or de-
creases. Such changes have been attributed to an
accelerated decrease in lean mass and an initial in-
crease and later decrease in fat mass [23].
Women exhibit a generally similar pattern [23].
Intramuscular and visceral fat increase with ageing,
while subcutaneous fat declines [24e26].
Our results are in agreement with other studies [12].
Compared to the normal group, the CVD risk was not
significantly increased among the sarcopenic or obese
groups but was increased by 23% (95% CI: 0.99e1.54,
p ¼ 0.06) in the sarcopenic-obese group. Using a
prospective cohort study design, Baumgartner and
colleagues found that elderly sarcopenic obesity sub-
jects are 2.5 times more likely to experience a decline
in physical function compared to elderly subjects with
normal body compositions. The purely obese and
purely sarcopenia persons were not found to be at risk
in this study.
The inclusion of physical activity and common
CVD risk markers as covariates in the mediation
regression models attenuated the risk estimates for the
CVD outcomes among the sarcopenic-obesity subjects.
The increased risk of CVD associated with sarcopenic
obesity based on muscle strength was attenuated from
23 to 18% after controlling for physical activity and
further reduced to 6% after controlling for CVD risk
markers. These results suggest that the pathway
through which sarcopenic obesity influences CVD
outcomes, at least in part, involves physical activity
and common CVD risk markers; i.e., sarcopenic
obesity might lead to inactivity and an elevation inCVD risk factors, which in turn increases the risk of
CVD events.
Previous research supports the protective role of
muscle strength; increases in strength have been
associated with improvements in high-density lipo-
protein cholesterol, blood pressure and insulin sensi-
tivity. Furthermore, there is an abundance of evidence
indicating that abdominal obesity among the elderly
negatively affects several CVD risk markers, including
hypertension, impaired glucose metabolism and
dyslipidaemia.
Our study had several limitations that must be
considered. First, the cross-sectional design precluded
the identification of causal relationships or changes
over time. Longitudinal studies, such as the Western
study on this issue [27], should be conducted in older
Asian populations.
Conclusion
In conclusion, our results revealed that the combi-
nation of sarcopenia and obesity might have a dynamic
and negative affect on the ageing process in the elderly.
Specifically, the prevalence of sarcopenic obesity was
higher among the old women than the old men.
Furthermore, the sarcopenic obese old men and women
were more likely to experience problems with
mobility, self-care, and usual activities than were the
subjects in the normal body composition group after
adjusting for potential risk factors. Additionally the
sarcopenic non-obese men and women experienced
less functional limitation than did the sarcopenic obese
individuals.
Taken together, these findings suggest that the
ability to correctly diagnose this condition is becoming
more important. Further studies are needed to aid the
prevention and management of sarcopenic obesity. To
achieve this goal, additional research on the diagnosis
of sarcopenic obesity and its aetiology and clinical
impact in the older population is needed.References
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